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CULTURES (pp. 58)
Director: Charles L. Eyer, Ph.D.
Thesis Abstract
Increased worldwide use of organotins has raised concerns about ecological 
contamination and health risks. Organotins produce a range of toxicological effects 
including damage to several organ systems in mammals and humans. Several of these 
compounds produce serious deficits in the central nervous system. Our investigation 
characterized organotin toxicity in a rat astrocyte model. Time and concentration effects 
o f trimethyltin (TMT), triethyltin (TET), tributyltin (TBT), and triphenyltin (TPT) were 
determined by measuring lactate dehydrogenase (LDH) release, 3-(4,5-dimethylthiazol-2- 
yl)-2,5-diphenyl tétrazolium bromide (MTT) reduction to formazan, and observing 
morphological changes. Established subtoxic concentrations of TMT and TET, two 
neurotoxic organotins, and TPT, a non-neurotoxic organotin, were used to investigate the 
effects of organotins on astrocytic glutamate homeostasis.
Cytotoxicity studies showed a relative order of potency of TPT>TBT, TE1>TMT. This 
order is similar to that reported in other cell types. TMT required higher concentrations 
and longer exposure times to produce the same toxicity observed after exposure of 
astrocytes to the other organotins. Observed morphological changes correlated with 
cytotoxicity results. Data from the MTT assay showed that 10 pM TMT and TET 
produced an initial increase in metabolic activity, which in the case of TMT occurred 
prior to the onset of cytotoxicity. The same concentration of TBT and TPT did not cause 
this increase.
We investigated the effects of subtoxic concentrations of organotins on glutamine 
synthetase (OS) and glutamate transport, two key components of glutamate homeostasis 
in astrocytes. TMT, TET, and TPT decreased OS activity. Only TET decreased both OS 
and glutamate transport activity. The time and concentration response of cytotoxicity and 
changes in astrocytic glutamate homeostasis found in our study do not correlate with in 
vivo pathology, but may account for regional CNS specificity after organotin exposure.
in
TABLE OF CONTENTS
ABSTRACT-------------------------------------------------------------------------------------------------ii
LIST OF FIGURES--------------------------------------------------------------------------------------- iv
ACKNOWLEDGMENTS--------------------------------------------------------------------------------vi
INTRODUCTION----------------------------------------------------------------------------------------- 1
CHAPTER 1: Differential Cytotoxicity of Four Organotins in Primary Astrocyte 
Cultures
Abstract---------------------------------------------------------------------------------- 5
Introduction------------------------------------------------------------------------------ 6
Methods---------------------------------------------------------------------------------- 7
Results----------------------------------------------------------------------------------— 11
Discussion-------------------------------------------------------------------------------- 22
CHAPTER 2: Organotins Disrupt Components of Glutamate Homeostasis in Rat 
Astrocyte Cultures
Abstract-----------------------------------------------------------------------------------28
Introduction-------------------------------------------------------------------------------29
Methods-----------------------------------------------------------------------------------31
Results------------------------------------------------------------------------------------- 36
Discussion--------------------------------------------------------------------------------47
CONCLUSIONS------------------------------------------------------------------------------------------- 52
BIBLIOGRAPHY------------------------------------------------------------- --------------------------- 53
IV
LIST OF FIGURES
CHAPTER 1 : Differential Cytotoxicity of Four Organotins in Primary Astrocyte 
Cultures
Figure 1 A: Cytotoxicity by LDH Release after 24 hr Organotin Exposure 14
Figure IB: Cytotoxicity by LDH Release after 48 hr Organotin Exposure---------- 15
Figure 1C: Cytotoxicity by LDH Release after 72 hr Organotin Exposure 16
Figure 2: Photomicrographs of Astrocytes Exposed to 10 pM Organotins for
24 h r ------------   17
Figure 3: Photomicrograph of Astrocytes Exposed to 10 pM TMT for 72 h r --------- 18
Figure 4A: Comparison of LDH and MTT after 24 hr, 10 pM
Organotin Exposure--------------------------------------------------------------------- 19
Figure 4B; Comparison of LDH and MTT after 48 hr, 10 pM
Organotin Exposure--------------------------------------------------------------------- 20
Figure 4C: Comparison of LDH and MTT after 72 hr, 10 pM
Organotin Exposure--------------------------------------------------------------------- 21
CHAPTER 2: Organotins Disrupt Components of Glutamate Homeostasis in Rat 
Astrocyte Cultures
Figure lA: TMT Cytotoxicity------------------------------------------------------------------ 39
Figure IB: TET Cytotoxicity------------------------------------------------------------------- 40
Figure 1C: TPT Cytotoxicity------------------------------------------------------------------41
Figure 2: MTT Reduction after 72 hr exposure to IpM Organotins-------------------42
Figure 3; GS Activity after Acute Organotin Exposure to Purified
Sheep Brain GS and Cell Homogenates---------------------------------------------43
Figure 4: Astrocytic GS Activity after Organotin Exposure-----------------------------44
Figure 5: Astrocytic Glutamate Uptake after Acute 1 pM Organotin Exposure 45
Figure 6 : Astrocytic Glutamate Uptake after 1 pM Organotin Exposure------------46
VI
ACKNOWLEDGMENTS 
I would like to thank Dr. Vernon Grand and the Department of Pharmaceutical 
Sciences for encouraging me and giving me an opportunity to continue my science 
education here in Montana. I thank my advisor Dr. Charles Eyer for giving me an 
opportunity to jump into his organotin project, and for all his patience and support along 
the way. I thank Dr. Richard Bridges for his advice and consultation in experimental 
design, revie^ving of manuscripts, providing intellectual challenges when I needed them, 
and constantly pushing me further than I thought I could go; Dr. Diana Lurie for helping 
me with microscopy, reading of drafts, and continual encouragement; Dr. Keith Parker 
for his advice in cell culture and always offering a kind word when problems occurred; 
and Dr. Charles Thompson for agreeing to sit on my committee at the last minute and for 
patiently waiting as we worked out details of the project. I especially thank Sarj Patel for 
his friendship and leading me through the glutamate uptake assays. I also want to thank 
the friends I’ve made along the way: John, Colleen, Danielle, Sparky, Jeff, Celine, and 
Tom for their constant encouragement that kept me going through adverse conditions. I 
also thank my Mom, brothers, and sisters in Baltimore for their long distance support!
Introduction 
Organotins
Organotins are synthetic compounds many of which produce distinct toxicity to a 
variety of living species including man (Barnes and Stoner, 1959). The mono-, di-, tri-, 
or tetra- substituted organotins have widespread use in the chemical, agriculture, wood 
products and shipping industries (Boyer, 1989). As of the mid-1980’s, 50,000 tons of 
organotins were produced annually. Studies of environmental impact show 
biomethylation of inorganic tin, bioaccumulation in heavily shipped waterways, and 
bioconcentration of organotins in shellfish and bottom feeders (Clarkson et al, 1987). 
Trimethyltin (TMT) and triethyltin (TET) are both neurotoxic and are used in agriculture 
and the plastics industry (McMillan and Wenger, 1985). Tributyltin (TBT) and 
triphenyltin (TPT) are both used in the shipping industry in anti-fouling paint and have 
been shown to contaminate large shipping harbors (Morcillo et al, 1997).
Triorganotins have been shown to be the most potent organotin toxicants in 
mammals (Boyer, 1989; McMillan and Wenger, 1985). Symptoms of triorganotin 
exposure include aggression and memory loss (TMT), cerebral edema (TET), dermal 
irritation (TBT), and hepatic and biliary inflammation (TBT, TPT). Increasing alkyl 
chain length and lipophilicity alter the specific toxic effects of triorganotins. TET shows 
the highest mammalian toxicity, TBT and TPT show highest activity against fungi, and 
TMT against insects (Nicklin and Robson, 1988).
Both TBT and TPT cause immunotoxic thymic damage. Exposure of these 
compounds also leads to renal and hepatic damage (Nicklin and Robson, 1988). Even
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though no in vivo CNS pathology of TBT or TPT has been found (Bouidin et al, 1981), 
TPT has been shown to accumulate in brain tissue (Heath, 1963). Both TBT and TPT 
have been implicated in disruption of intracellular calcium movement and apoptotic cell 
death in neuronal type PC I2 cells (Viviani, et a i, 1995). TBT has been found to interact 
with cytochrome P450-1A metabolism (DeLong and Rice, 1997) and to decrease 
norepinephrine levels in the CNS (Boyer, 1989) after in vivo exposure. Although TPT is 
not known as a neurotoxicant, a case study of TPT exposure has described CNS 
symptoms including severe ataxia, blurring of vision, disturbance of consciousness and 
confusion (Wu et a l, 1990).
Distribution studies of TMT and TET show widespread CNS accumulation of 
both organotins with differences in elimination rates (Cook et al, 1984). In these studies 
the half life in brain tissue for TMT was reported as 10.2 days and 4.6 days for TET.
Both TET and TMT alter oxidative phosphorylation and disrupt Na^ -K^ -ATPases 
(Aldridge and Street, 1971). TET causes demyelination and cerebral edema with some 
seizure activity (Kimbrough, 1976). TMT causes specific pathology in the limbic system 
of the CNS with neuronal loss in the hippocampal CA region (Chang, 1986). Symptoms 
of TMT exposure include behavioral changes, seizures, and memory loss (Brown et a l, 
1979; Dyer et a l, 1982). It is unclear why TMT neurotoxicity exhibits such regional 
specificity and whether the primary insult occurs to glia or neurons.
Glutamate Activity in the Hippocampus
In addition to being a target of TMT toxicity, the hippocampus and related limbic 
structures have been shown to be vulnerable in several neurological insults, including 
hypoglycemia, anoxia, ischemia and epilepsy (Cotman et al., 1989). Glutamate is the 
primary excitatory amino acid (EAA) neurotransmitter in the mammalian nervous system 
with a high concentration of receptors in the limbic region (Monaghan et al, 1989). 
Elevated levels of glutamate can cause neuronal damage known as excitotoxicity 
(Rothman and Olney, 1989). Over-activation of EAA receptors results in a disruption of 
N a \ Cl", and Ca^ flux that can produce osmotic imbalances and cell swelling. Increased 
intracellular levels of calcium can lead to increased activity of potentially destructive 
enzymes such as lipases, proteases and oxidases. Because of the dual nature of glutamate 
as a neurotransmitter and potential toxin, levels must be closely regulated in the CNS 
(Bridges and Cotman, 1991).
Astrocyte Regulation of Glutamate
The astrocyte plays a role in the maintenance of glutamate homeostasis in the 
CNS (Norenberg and Martinez-Hemandez, 1979). Extracellular glutamate levels are 
decreased by rapid Na^^-dependent astrocytic glutamate uptalce. Once inside the cell, 
glutamate is converted to glutamine by the astrocyte specific enzyme glutamine 
synthetase (GS) (EC 6 .3.1.2) (Farinelli and Nicklas, 1992). The non-excitotoxic 
glutamine is then transported back to the neuron and reconverted to glutamate by 
neuronal glutaminase (EC 3.5.1.2). A decrease in the ability of the astrocyte to maintain
this glutamate flux can contribute to elevated levels of glutamate in the synapse, 
potentially facilitating excitotoxic injury (Takahashi et al, 1997).
TMT has been shown to interact with several neurotransmitters including the 
glutamatergic system (Earley et al, 1992). TMT increases glutamate release in 
hippocampal slices (Patel et al, 1990) and cortical slices (Dawson et al, 1995) as well as 
decreasing glutamate uptake (Aschner et al, 1992). In vivo TMT exposure has also been 
shown to increase levels of the astrocytic marker glial fibrillary acidic protein (GFAP) 
(Brock and O'Callaghan, 1987). TMT effects on specific astrocyte functions related to 
glutamate homeostasis are unknown. A more detailed investigation of the effect of 
organotins on astrocytic glutamate homeostasis is needed.
The purpose of this investigation is to define the relative toxicity of organotins in 
primary astrocyte culture and explore the possible interaction of these compounds with 
glutamate homeostasis in astrocytes. Time and concentration effects of organotins will 
be determined in primary astrocyte cultures. An established subtoxic concentration will 
be used to define effects of organotins on astrocytic GS and glutamate transport.
Chapter 1: Differential Cytotoxicity of Four Organotins in Primary Astrocyte
Cultures
Abstract
The role of astrocytes in organotin toxicity was investigated by comparing the 
cytotoxicity of trimethyltin (TMT), triethyltin (TET), tributyltin (TBT), and triphenyltin 
(TPT) in rat cortical astrocyte cultures. Time and concentration effects of the organotins 
were determined by measuring lactate dehydrogenase (LDH) (EC 1.1.1.27) release, 3- 
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tétrazolium bromide (MTT) reduction, and by 
observing morphological changes. TET, TBT, and TPT produced cytotoxicity after 24 hr 
exposure to a concentration as low as 2.5 pM. One hundred micromolar TMT did not 
produce toxicity until 48 hr after exposure. Observed morphological changes after 10 
pM organotin exposure for 24 hr paralleled the increases in extracellular LDH. Twenty- 
four hour exposure to 10 pM TMT increased MTT reduction to formazan without 
affecting LDH release. In contrast, TET exposure increased formazan production while 
decreasing cell viability measured by LDH release. TBT and TPT decreased formazan 
production and increased LDH release. The increase in MTT reduction after TMT and 
TET exposure suggests a burst of mitochondrial activity prior to cell death. The four 
organotins exhibited marked differences in relative potency and the time required for 
development of cytotoxicity in astrocyte cultures. TMT required both higher 
concentrations and more time to produce toxicity than the other three organotins. The 
relative toxicity of TMT, TET, TBT, and TPT in astrocyte cultures does not reflect the in 
vivo specificity of these organotins in the CNS.
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Introduction
Organotins are widely used in industry and agriculture as plastic stabilizers, 
molluscicides, insecticides, and fungicides (Nicklin and Robson, 1988). Triethyltin 
(TET) and trimethyltin (TMT) are known to cause damage in the central nervous system 
(CNS). TET is a demyelinating agent which causes edema and swelling within the CNS 
(Kimbrough, 1976). TMT primarily affects the hippocampus causing pyramidal cell loss 
(Chang, 1986). The higher molecular weight organotins such as tributyltin (TBT), and 
triphenyltin (TPT) are known to be immunotoxic, disrupting thymocyte and lymphocyte 
function as well as causing renal and hepatic damage (Snoeij et al., 1987). Some 
reversible nervous system damage has been seen in case studies of acute TPT exposure 
(Wu et al., 1990).
Astrocytes play a supportive and interactive role with neurons in maintaining 
ionic and chemical homeostasis (Vemadakis, 1996; Silver et al, 1997). These cells have 
been implicated in injury and diseases such as amyotrophic lateral sclerosis (ALS) and 
ischemia (Walum et a l, 1995). Several studies have linked TMT neurotoxicity to 
astrocytes. Aschner and Aschner (1992) suggest that astrocytes may represent an 
important link in the CNS damage produced by TMT because of evidence of prominently 
swollen astrocytes without neuronal involvement after in vivo exposure. In vivo exposure 
to TMT also produces a transient astrocytic response seen by an increase in the specific 
cell marker glial fibrillary acidic protein (GFAP) (Brock and O'Callaghan, 1987).
In order to better understand the role of astrocytes in TMT neurotoxicity our 
laboratory has investigated the comparative toxicity of organotins in cortical astrocyte
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cell cultures. No neurotoxicity has been documented after in vivo exposure to TBT or 
TPT (Nicklin and Robson, 1988). TET is known to target myelin producing ceils which 
should not be present in primary astrocyte cultures. If astrocytes play a key role in TMT- 
induced neurotoxicity then this organotin should show some unique feature not seen with 
organotins exhibiting different toxic specificity.
In our astrocyte cell culture system, TMT produced a delayed cytotoxicity 
confirmed by LDH release and photomicrographs. After 24 hr exposure, 2.5 pM and 
greater concentrations of the other organotins produced cytotoxicity, paralleled by 
observable morphological change. MTT studies showed an initial increase in 
mitochondrial activity after TMT and TET exposure. This increase was followed by a 
decrease at 72 hr. TBT and TPT exposure decreased mitochondrial activity at all time 
points.
Methods
Materials:
Pregnant female Sprague-Dawley rats were obtained from Simonsen Labs 
(Gilroy, CA). Rats were maintained on a 12 hr light-dark cycle with food and water ad 
libitum. Cell culture media was purchased from Gibco-BRL (Grand Island, NY) and 
fetal calf serum (PCS) from Hyclone (Logan, UT). All cell culture plasticware was 
obtained from Fisher Scientific (Santa Clara, CA). All chemicals were purchased from
8
Sigma (St. Louis, MO), except trimethyltin chloride, triethyltin chloride, tributlytin 
chloride, and triphenyltin chloride (Aldrich, Milwaukee, WI)
Cell Culture:
Primary cultures of type I astrocytes were prepared from 4 day old rat pups as 
described by McCarthy and de Vellis (1980). Cortical hemispheres were dissected free 
and the meninges and subcortical structures removed. After disruption of the cortical 
tissue by trituration, the cells were plated in a 1:1 mixture of Dulbecco’s Modification of 
Eagle’s Medium and Ham’s F I2 medium. Media was supplemented by addition of 15 
mM HEPES and 1.2 g/L of sodium bicarbonate, penicillin (100 units/ml), streptomycin 
(100 pg/ml), and Fungizone (0.1 pg/ml). The pH was adjusted to 7.4. The cells were 
cultured in poly-D-lysine coated 80 cm  ̂flasks maintained at 37° C in a humid 
atmosphere containing 5% COj. The medium was supplemented with 15% FCS during 
the initial plating and then maintained with 10% FCS.
When 60-70% confluent, the cells were shaken in fresh media on a Hi-Line orbital 
shaker (280 RPM, 24 hr) to remove oligodendrocytes, type II astrocytes, and microglia. 
Three days later the astrocytes were harvested by trypsinization and plated into uncoated 
Falcon 12 well plates at a density of 10̂  cells/ml. These secondary cultures were 
maintained in a similar environment with media changes every 3-4 days and allowed to 
reach confluence (14-21 days). Homogeneity of astrocyte cultures was monitored by 
microscopic observation and by the presence of the astrocytic marker GFAP. Cultures 
were found to be > 95% GFAP (+).
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Cells were viewed and morphological changes documented by photomicrographs 
on an Olympus Inverted Research Microscope, Model IMT-2.
Organotin Treatments:
TMT, TET, and TBT were dissolved in distilled, deionized H^O, filter sterilized, 
and introduced into the media to achieve the appropriate concentrations. TPT was 
dissolved in 100% DMSG, diluted into media, sterile filtered and further diluted in media 
to appropriate concentrations. DMSG did not exceed 0.1% in final dilution, a 
concentration which did not change LDH release or formazan production in control 
experiments.
Lactate Dehydrogenase (LDH):
Cell death was estimated by measuring the extent of lactate dehydrogenase (LDH) 
leakage into the culture medium (Vassault, 1983; Koh and Choi, 1987). Extracellular 
fluid was aspirated and cells were lysed with 0.1% Triton-X in serum-free culture media. 
LDH activity was determined in the media and the cell lysate fraction by measuring the 
rate of disappearance of NADH from the reaction mixture (AGD3 4 0 ) using a Molecular 
Devices 96 well plate reader and SGFTmax PRG software. Percent extracellular LDH 
was calculated using the formula: % extracellular LDH -  100 x [(extracellular 
AGD/min) 4 - (extracellular + intracellular AGD/min)].
10
M TT Reduction:
A second cell viability method was used to measure the reduction of a water 
soluble tétrazolium salt (MTT) to formazan (Slater, 1963; Mossman, 1983). Briefly, 3- 
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tétrazolium bromide (MTT) was dissolved in 
distilled, deionized H2 O at 5 mg/ml and further diluted to a 1:10 working solution in 
Kreb’s Ringer Buffer (KRB). Extracellular media was aspirated from 12 well plates. A 
volume of 200 pi of the MTT working solution, and 300 pi of KRB was added to each 
well. Cells were incubated for 3 hr at 3 7*̂ C. After 3 hr, 1.5 ml of 0.1 M HCl in 
isopropanol was added to the wells to solubilize the purple formazan crystals. Sealed 
well-plates were refrigerated overnight, and read on a Beckman DU450 
spectrophotometer at 560 nm. Results were reported as a percent of the optical density 
produced by control wells from the same culture plate.
The optical density values produced in the MTT assay are directly proportional to 
mitochondrial activity and reflect cell viability rather than cell death (Mosmann, 1983).
In experiments comparing the values obtained in the two assays (LDH and MTT) LDH 
data was expressed as percent intracellular LDH. This normalized the results of the two 
assays with 1 0 0 % representing no cell death, making it possible to compare values from 
both assays on the same set of axes.
I l
Statistics:
The LDH and MTT experiments were repeated in different culture preparations 
with n = 6  to 26 for each concentration and time point. Descriptive statistics, unpaired t 
tests, ANOVA and Tukey’s multiple comparison test were determined using the 
GBSTAT® software program.
Results
Figure 1 shows the time and concentration dependence of astrocyte cytotoxicity 
measured by LDH release. After 24 hr (Fig. 1 A) exposure, differences in the time and 
concentration effects of cytotoxicity can be observed. Concentrations of TPT (2.5 |iM 
and greater) produced almost complete cell death. TET and TBT produced similar dose- 
response curves with discernible cytotoxicity occurring at concentrations of 2.5 pM and 
greater. TMT failed to produce any cytotoxicity at concentrations up to 100 pM.
After 48 hr (Fig. IB) exposure to TBT and TET concentrations of 2.5 pM and 
greater produced significant increases in LDH release. Almost complete cell death 
occurred at 10 pM and greater concentrations. TMT cytotoxicity only occurred following 
100 pM exposure.
Increased cytotoxicity was evident after 72 hr exposure to the organotins (Fig.
1C). A slight increase in LDH release was produced by 1 pM TPT. No other organotin 
produced observable cytotoxicity at this lowest concentration, but TET and TBT showed
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further increases in LDH release at the 2.5 and 5 pM concentrations. Concentrations of 
TMT less than 10 |iM did not produce any significant increase in LDH release. Figure 1 
shows that TMT was the least potent organotin used in these studies, and moreover TMT 
toxicity was not detectable until after 24 hours.
The differences in morphological changes between TMT and the other organotins 
correlated with differences in LDH release observed after 24 hr exposure. Figure 2 shows 
a morphological comparison of 10 jaM organotin exposure for 24 hr in primary astrocyte 
cultures. Control cells are shown in Fig. 2A. TMT (Fig. 2B) exposure did not cause an 
observable morphological change. After 24 hr, the other organotins (TET, TBT and TPT) 
had produced significant LDH leakage and visible morphological changes (Fig. 2C,D,E) 
including cell shrinkage with elongated processes, nuclear prominence, and holes in the 
monolayer of cells.
After 72 hr exposure, TMT (Fig. 3) still showed different morphological changes 
from those seen after 24 hr exposure to TET, TBT, and TPT (Fig. 2). The astrocytes 
shown in Figure 3 were noticeably larger and swollen in comparison to control cells with 
vacuole formation. Following a 72 hr exposure to 10 pM TET, TBT, and TPT cells were 
no longer present in the culture wells.
The MTT reduction assay was used as a second cell viability assay. Figure 4 is a 
comparison of cell viability measured by intracellular LDH and MTT reduction. Figure 
4A shows that 24 hr after exposure to 10 pM TMT and 10 pM TET a significant increase 
in formazan production occurred. The percentage of viable cells measured by LDH was 
not affected by TMT exposure. TET produced a significant decrease in cell viability.
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TBT produced a comparable reduction in both assays. TPT caused a significant decrease 
in reduction capabilities of the astrocytes (MTT assay) with less than 3% of control levels 
of formazan produced compared to 32 ± 3.2% intracellular LDH. After 48 and 72 hr 
exposure to TBT and TPT reduced formazan production to less than 5% of control (Fig. 
4B, C). Figure 4B shows that after TET exposure for 48 hr, only 12% of the remaining 
cells were viable. This decreased population of cells produced 90% of control levels of 
formazan. After 72 hr exposure to 10 pM concentrations, all the organotins showed a 
loss of cell viability in both the MTT and the LDH assays (Fig. 4C).
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Figure 1: Primary astrocytes were exposed to 1-100 pM concentrations of trimethyltin 
(TMT), triethyltin (TET), tributyltin (TBT), or triphenyltin (TPT) and percent (%) 
extracellular LDH was determined. Each data point represents n = 6  to 26. (A) 24 hr 
organotin exposure, (B) 48 hr organotin exposure, (C) 72 hr organotin exposure. * = 
lowest organotin concentration shown with a significant increase in LDH release (p < 
0.01). Higher concentrations also produced significant increases in extracellular LDH.
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Figure l: Primary astrocytes were exposed to 1-100 concentrations of trimethyltin 
(TMT), triethyltin (TET), tributyltin (TBT), or triphenyltin (TPT) and percent (%) 
extracellular LDH was determined. Each data point represents n = 6  to 26. (A) 24 hr 
organotin exposure, (B) 48 hr organotin exposure, (C) 72 hr organotin exposure. * -  
lowest organotin concentration shown with a significant increase in LDH release (p < 
0.01). Higher concentrations also produced significant increases in extracellular LDH.
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Figure 1: Primary astrocytes were exposed to 1 - 1 0 0  concentrations of trimethyltin 
(TMT), triethyltin (TET), tributyltin (TBT), or triphenyltin (TPT) and percent (%) 
extracellular LDH was determined. Each data point represents n = 6  to 26. (A) 24 hr 
organotin exposure, (B) 48 hr organotin exposure, (C) 72 hr organotin exposure. * = 
lowest organotin concentration shown with a significant increase in LDH release (p < 
0.01). Higher concentrations also produced significant increases in extracellular LDH.
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Figure 2: Photomicrographs of 
astrocytes exposed to 10 |aM 
organotins for 24 hr. (A) control cells; 
a flat mono-layer of polygonal cells, 
(B) TMT : some spacing between cell 
bodies, but mostly flat mono-layer of 
cells, (C) TET : nuclear prominance 
with elongated processes extending 
between holes in mono-layer, (D)
TBT: cell shrinkage with nuclear 
prominance, extended processes and 
holes between cell bodies, (E) TFT : 
cell shrinkage with extended processes 
and gaping holes between cell bodies. 
Bar = 30 pm.
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&
Figure 3: Astrocytes were exposed to 10 pM TMT for 72 hr. Cells appear large, 
rounded and swollen with some process extension, vacuole formation, and holes in the 
mono-layer. Control cells were still identical to those shown in Fig. 2A after 72 hr. Bar 
30 \ i m .
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Figure 4 : Cells were exposed to 10 pM TMT, TET, TBT or TPT. The Y-axis represents 
percent (%) intracellular LDH in LDH experiments and % control of formazan production 
in MTT experiments. (A) 24 hr exposure, (B) 48 hr exposure, (C) 72 hr exposure. 
Significant diiferences between LDH and MTT values were determined by the unpaired 
Student’s t test, (n = 6  to 26, **p < 0.01)
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Figure 4; Cells were exposed to 10 loM TMT, TET, TBT or TPT. The Y-axis represents 
percent (%) intracellular LDH in LDH experiments and % control of formazan production 
in MTT experiments. (A) 24 hr exposure, (B) 48 hr exposure, (C) 72 hr exposure. 
Significant diiferences between LDH and MTT values were determined by the unpaired 
Student’s t test, (n = 6 to 26, **p < 0.01)
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Figure 4: Cells were exposed to 10 p-M TMT, TET, TBT or TPT. The Y-axis represents 
percent (%) intracellular LDH in LDH experiments and % control of formazan production 
in MTT experiments. (A) 24 hr exposure, (B) 48 hr exposure, (C) 72 hr exposure. 
Significant diiferences between LDH and MTT values were determined by the unpaired 
Student’s t test, (n = 6  to 26, **p < 0.01)
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Discussion
The order of organotin effectiveness producing cytotoxicity in our astrocyte 
cultures was found to be TPT>TBT, TET>TMT. TET is known to produce neurotoxicity 
by causing changes in myelination, but not by affecting astrocyte function (Aschner and 
Aschner, 1992). TBT and TPT are known to be immunotoxic (Nicklin and Robson,
1988), but gliotoxicity has not been reported. In our study higher concentrations and 
longer periods of time were required to produce cytotoxicity with TMT than with any of 
the other three organotins. Exposure of thymocyte cultures to organotins produces the 
same relative order of cytotoxicity (TPT>TBT>TET>TMT) after 10 to 30 hr exposure to 
concentrations of 0.1-10 pM (Snoeij et a l, 1986). Thompson, et al. ( 1996) have 
compared organotin toxicity in immortal cell lines (neuroblastomas, b-cell lines, NIH- 
3T3 fibroblast and TC-7 kidney cells) and primary cells. They found the immortal cell 
lines more sensitive to TBT and TET, but resistant to TMT. Primary neuronal and mixed 
glial cultures exhibited the same order of sensitivity with TC5 0  concentrations between 
0.01 pM and 5 pM. The concentration range of organotin toxicity in primary astrocytes 
(Fig. 1 ) correlates with the previous studies. It appears that the time and concentration 
effect of organotin cytotoxicity that we observed in cultures of primary cortical astrocytes 
correlates with that reported by others in isolated cell cultures. However, Richter- 
Landsberg and Besser (1994), using the neutral red cytotoxicity assay, found a half- 
maximal concentration of TMT at 2.5 pM. The above studies also used slightly different 
cell culture preparations with a 1 0 % CO2 environment and organotin treatments after 
astrocytes were 4-5 weeks in vitro. The differences between effective toxic TMT
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concentrations could be explained by differences in how cytotoxicity was measured and 
culture conditions.
The photomicrographs in Fig. 2 and 3 also show different time and concentration 
effects of cell damage after TMT exposure. Apoptotic cell death, determined by DNA 
fragmentation, has been implicated 24 hr after IpM or 2.5 pM TPT or 2.5 pM TBT 
exposure for 30 min in PC 12 cells (Viviani et al^ 1995). The apoptotic cell death 
described above accompanies LDH release. It is possible that the differences in 
morphology we have observed are because of apoptotic cell death in astrocytes exposed 
to TBT or TPT. Even after 72 hr, increased cell swelling after TMT exposure implies a 
loss of osmotic control that was not seen with the other organotins. This osmotic effect 
has been observed by others and is thought to be related to inhibition of astrocytic Na^ - 
- ATPase (Aschner and Aschner, 1992).
The reduction of MTT to formazan is thought to occur in the mitochondria. 
However, more recent investigations have suggested that the MTT assay is an indicator of 
overall cell reductive capability (Liu et al., 1997) and not limited to mitochondrial 
reductases. The increase in formazan production seen after 10 pM TMT exposure 
suggests an increase in cell metabolic activity that precedes the cytotoxicity observed 
with the LDH assay. After 24 hr exposure to 10 pM TET, astrocytes maintained 100% of 
control levels of formazan production with an 80% reduction of cell population (Fig. 3A). 
This same concentration of TMT and TET produced a significant decline in formazan 
production after 72 hr. The increase in MTT reduction after 24 hr exposure to TMT and 
TET followed by a decrease at later times suggests a burst of mitochondrial or metabolic
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activity in cells that later go on to die. In related studies, this same increase in formazan 
production was seen in cell cultures derived from nitrosoethylurea-induced brain tumors, 
after exposure to the mitochondrial protonophore uncoupler, carbonyl cyanide p~ 
trifluoromethoxyphenylhydrazone (FCCP) (Liu et al., 1997). TMT and TET have been 
shown to inhibit oxidative phosphorylation (Aldridge and Street, 1971), disrupt the 
hydroxyl-chloride gradient, and inhibit ATP synthesis (Aldridge, 1976) all of which 
would compromise cellular energy metabolism. Since FCCP is a known protonophore 
uncoupler that increases MTT reduction (Liu et al., 1997), uncoupling of oxidative 
phosphorylation or disruption of cellular energy metabolism after exposure to TMT or 
TET could account for the patterns of formazan production we observed in MTT 
reduction.
The neurotoxic organotins appear to have some similar mechanisms of action 
distinct from TBT and TPT. The MTT results after TMT and TET exposure suggest an 
increase in metabolic activity in the astrocytes. Over time this increase may lead to 
production of endogenous cytotoxic elements such as reactive oxygen species, or to 
release of intracellular stores of calcium. TBT and TPT have been shown to rapidly 
increase intracellular calcium levels by increasing transmembrane movement and 
promoting release from intracellular stores (Corsini et al, 1997; Viviani et al, 1995; 
Zazueta et a/., 1994). The study by Viviani et al (1995) also reported that TET has a 
minimal effect on calcium movement and TMT has no effect at all. The ability of TBT 
and TPT to rapidly elevate intracellular calcium suggests a different mechanism of action 
between the smaller, neurotoxic alkyl tins, and the larger, non-neurotoxic compounds.
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The delayed cytotoxicity shown by TMT in the LDH studies and differences in 
morphological changes between TMT and TET suggest differing mechanisms of toxicity. 
Concentrations as high as 100 pM TMT did not produce measurable cytotoxicity until 48 
hr exposure. This initial TMT cytotoxicity occurred 24 hr after a 2.5pM concentration of 
TET produced LDH leakage. While both compounds altered mitochondrial activity in 
our studies, TMT caused less cell damage. A minor disruption in cellular energy 
metabolism could account for the delay in measurable TMT cytotoxicity. The results 
from the LDH and MTT experiments indicate that both TMT and TET can alter cell 
metabolism prior to cell death, while TET rapidly disrupts the cell membrane.
The cytotoxicity observed in astrocyte cultures does not appear to reflect the 
tissue specificity seen after in vivo organotin exposure. Concentrations of lOmg/kg of 
TBT and 30 mg/kg of TPT do not produce CNS pathology in rat studies (Boyer, 1989).
In vivo distribution studies have detected TPT in CNS tissue up to 38 days after 
administration (Heath, 1963). TPT has also been shown to increase the peak amplitude 
and prolong the decay phase of sodium currents, and decrease the delayed outward 
potassium currents in hippocampal pyramidal neurons (Oyama and Akaike, 1990). A 
human case study (Wu, Chang, and Chiu, 1990) implicated TPT as causing reversible 
neurological symptoms such as ataxia, confusion and visual disturbances. Reduction of 
CNS norepinephrine levels has been observed after in vivo TBT exposure (Boyer, 1989) 
indicating CNS involvement, but there were no neuropathological consequences from 
exposure. It is well documented that TET and TMT enter the CNS (Cook, Stine and
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Reiter, 1984), although regional distribution is not correlated with region specific 
pathology.
Another consideration of the in vivo environment is the presence of other glial 
cells in the CNS. Although an in vivo astrocytic response to TMT is well documented, 
purified cultures of astrocytes may lack other neural cell types that could contribute to 
toxicity. Oligodendrocytes and microglia could play a role in preventing the cellular 
toxicity seen after TET, TBT, and TPT exposure in isolated astrocyte cultures. These 
glial cells could also respond to TMT exposure by inducing cellular damage that could 
not be detected in our cell culture model. Microglia are known to secrete both 
neurotrophic and neurotoxic factors (Streit, 1996). TMT has been shown to cause an 
increase in number and/or clustering of microglia at very low concentrations (10 ’® M to 
1 O'* M) in aggregating cell cultures, but responses are inconsistent at higher 
concentrations (> 10'  ̂M) (Monnet-Tschudi et al., 1995). Streit (1996) has shown that 8 
mg/kg o f TMT in rabbits induced microglial activation preceding astrogliosis. A 
concentration of 8 mg/kg of TMT has also been implicated in elevation of inflammatory 
cytokine mRNA in rats. An astrocyte response marked by increased GFAP staining 
followed 2-4 days after exposure (Maier et al, 1995).
In conclusion, the four organotins displayed significant differences in relative 
potency and time of development of toxicity in astrocyte cultures. The non-neurotoxic 
organotins TBT and TPT produced a rapid cytotoxicity in astrocyte cultures as shown by 
LDH release, morphological changes and MTT reduction. We also observed early 
increases in cell metabolic activity after TMT and TET exposure, followed by
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cytotoxicity. The order of effectiveness observed in the primary astrocyte cultures was 
found to be TPT>TBT,TET>TMT, paralleling that found in other isolated cell cultures 
exposed to these organotins. However this order does not correlate with the reported 
regional specificity of these compounds as neurotoxicants. This lack of cytotoxicity by 
TMT in astrocytes does not rule out non-lethal, region specific changes in cell function 
that could disrupt the normal CNS environment and cause neurotoxicity.
Chapter 2; Organotins Disrupt Components of Glutamate Homeostasis 
in Rat Astrocyte Cultures
Abstract
The effects of subtoxic concentrations of three organotins on two key components 
of glutamate homeostasis in astrocytes were investigated. Appropriate subtoxic 
concentrations were determined for trimethyltin (TMT), triethyltin (TET), and 
triphenyltin (TPT) by measuring lactate dehydrogenase (LDH) release. A second cell 
viability assay measuring mitochondrial activity confirmed the relative non-toxic effects 
of these concentrations. Astrocytes were exposed to 1 pM or 5 pM TMT, 1 pM TET, 
and 1 pM TPT for 24-72 hours. Glutamine synthetase (OS) activity was measured in 
treated cells. All three organotins decreased OS activity. Control experiments showed 
that the organotins did not affect purified sheep brain OS or cell lysates after acute 
exposure. Glutamate transport activity was determined in astrocytes exposed to 1 pM 
TMT, 1 pM TET, and 1 pM TPT. TET decreased transport at all three exposure times. 
TPT decreased glutamate uptake after 24 hours, but the decrease recovered to control 
levels by 48 hours. TMT did not affect glutamate transport. None of the organotins 
altered uptake activity after acute exposure. Both TMT and TPT decreased GS without 
chronically disrupting glutamate transport. TET decreased both components of astrocytic 
glutamate homeostasis. The effects of organotins on astrocytic glutamate homeostasis do 
not explain the in vivo pathology or regional specificity of CNS cell damage that follows 
organotin exposure.
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Introduction
Organotins are synthetic products commonly used in industry and agriculture as 
plastic stabilizers, molluscicides, insecticides and fungicides (Nicklin and Robson, 1988). 
The triorganotins are the most toxic of the organotins to mammals. Small changes in 
chemical structure drastically alter their spectrum of toxicity (Nicklin and Robson, 1988). 
Trimethyltin (TMT) and triethyltin (TET) have been shown to cause neurological deficits 
in humans and animals (McMillan and Wenger, 1985). TMT causes a delayed 
neurotoxicity that is characterized by damage to the hippocampal region (Brown et a l, 
1979) and causes a dose-dependent decrease in serotonin, norepinephrine, and GAB A 
levels in different specific regions of the limbic system (Earley et a l, 1992). TET causes 
cerebral edema, primarily affecting white matter (McMillan and Wenger, 1985). 
Triphenyltin (TPT) causes cell damage in the thymus, kidney and liver (Nicklin and 
Robson, 1988). Although not known as neurotoxic, a case study of acute TPT exposure 
reported transient ataxia, confusion, and visual disturbances (Wu et a l, 1990).
Glutamate is an excitatory neurotransmitter found throughout the CNS 
(Monaghan et a l, 1989). Elevated levels of endogenous glutamate can overstimulate 
receptors and cause neuronal damage. This phenomenon is referred to as excitotoxicity 
(Rothman and Olney, 1987). A brief five minute, exposure to 50-100 pM concentrations 
of extracellular glutamate in vitro causes cell death to neurons, but not glial cells (Choi et 
a l,  1987). Investigators have shown evidence for TMT induced increases in glutamate 
release in partially depolarized hippocampal slice preparations (Patel et a l, 1990) and in 
cortical slices (Dawson et a l, 1995). TMT does not have excitotoxic actions itself, but
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produces a pattern of damage similar to the glutamate agonist, kainic acid (Dyer et al, 
1982). A 30 minute preincubation with 50 pM TMT caused a decrease in sodium 
dependent glutamate uptake in astrocytes (Aschner et a l, 1992) and 15 minute 
preincubation with 50 pM TMT decreased glutamate uptake in synaptosomal 
preparations (Naalsund and Fonnum, 1986). A model of slow neurotoxicity developing 
over several weeks has been proposed after inhibition of glutamate uptake in organotypic 
spinal cord cultures (Rothstein et al, 1993). This model is in contrast to the rapid 
neurotoxicity produced minutes after increased concentrations of extracellular glutamate 
occur in the CNS (Rothman and Olney, 1987). Decreased glutamate uptake by TMT 
could cause an increase in extracellular glutamate that might initiate an excitotoxic event 
or slow neurotoxicity. It is not known whether TET or TPT interferes with the 
glutamatergic system in the CNS.
Astrocytes play a critical role in maintaining glutamate homeostasis. Reducing 
the number of astrocytes present in a neuronal culture increases neuronal sensitivity to 
extracellular glutamate (Rosenberg and Aizenman, 1989). Astrocytes have at least two 
specific glutamate transporters (GLAST, GLTl) which play a role in removing excess 
glutamate from extracellular space (Rothstein et a l, 1996). The enzyme glutamine 
synthetase (EC 6.3.1.2) is also localized in astrocytes and detoxifies glutamate by 
converting it to the less excitotoxic amino acid glutamine (Farinelli and Nicklas, 1992). 
Both astrocytic glutamate transport and glutamine synthetase (GS) are important factors 
in the maintenance of extracellular glutamate levels and prevention of excitotoxicity.
31
The evidence of TMT involvement in the glutamatergic system in the CNS 
prompted our investigation of the effect of three organotins on glutamate homeostasis. 
The purpose of this investigation was to determine the effects of subtoxic concentrations 
o f the organotins on GS activity and glutamate transport in astrocytes. TMT exposure 
should show a specific effect on astrocyte function if disruption of glutamate homeostasis 
contributes to the selective toxicity of this neurotoxic organotin. Disruption of astrocyte 
function could offer a partial explanation of changes observed in CNS pathology after in 
vivo exposure to TMT. Our study compared the effects of TMT and TET, two neurotoxic 
organotins with differing regional specificity, and TPT, a non-neurotoxic organotin. We 
found that subtoxic concentrations of TMT, TET and TPT decreased GS activity, but 
only TET chronically decreased glutamate transport.
Methods
Materials:
Pregnant female Sprague-Dawley rats were obtained from Simonsen Labs 
(Gilroy, CA). Rats were maintained on a 12 hr light-dark cycle with food and water ad 
libitum. Cell culture media was purchased from Gibco-BRL (Grand Island, NY) and 
fetal calf serum (PCS) from Hyclone (Logan, UT). All cell culture plasticware was 
obtained from Fisher Scientific (Santa Clara, CA). All chemicals and sheep brain GS 
were purchased from Sigma (St. Louis, MO), except trimethyltin chloride, triethyltin 
chloride, and triphenyltin chloride (Aldrich, Milwaukee, WI).
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Cell Culture:
Primary cultures of type I astrocytes were prepared from 4 day old rat pups as 
described by McCarthy and de Vellis (1980). Cortical hemispheres were dissected free, 
meninges and subcortical structures removed. After disruption of the cortical tissue by 
trituration, the cells were plated in a 1:1 mixture of Dulbecco’s Modification of Eagle’s 
Medium and Ham’s F12 medium. Media was supplemented by addition of 15 mM 
HEPES, 1.2 g/L of sodium bicarbonate, penicillin (100 units/ml), streptomycin (100 
pg/ml), and Fungizone (0.1 pg/ml), and adjusted to pH 7.4. The cells were cultured in 
poly-D-lysine coated 80 cm" flasks maintained at 37° C in a humid atmosphere containing 
5% COj. The medium was supplemented with 15% FCS (vol/vol) during the initial 
plating and then maintained with 10% FCS (vol/vol).
When 60-70% confluent, the cells were shaken in fresh media on a Hi-Line orbital 
shaker (280 rpm, 24 hr) to remove oligodendrocytes, type II astrocytes, and microglia. 
Two or three days later the astrocytes were harvested by trypsinization and plated into 
uncoated Falcon 12 well plates at a density of 10̂  cells/ml. These secondary cultures 
were maintained in a similar environment with media changes every 3-4 days and 
allowed to reach confluence (14-21 days). Homogeneity of astrocyte cultures was 
monitored by microscopic observation and by the presence of the astrocytic marker 
GFAP. Cultures were found to be > 95% GFAP (+).
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Organotin Treatments:
TMT and TET were dissolved in distilled, deionized HjO, filter sterilized, and 
introduced into the media to achieve the appropriate concentrations. TPT was dissolved 
in 100% DMSO, diluted into media, sterile filtered, and further diluted in media to 
appropriate concentrations. DMSO did not exceed 0.1% (vol/vol) in final dilution. This 
solvent concentration did not cause increased LDH release.
Lactate Dehydrogenase (LDH):
Cell death was estimated by measuring the extent of lactate dehydrogenase (LDH) 
leakage into the culture medium (Vassault, 1983; Koh and Choi, 1987). Extracellular 
fluid was aspirated and cells were lysed with 0.1% (vol/vol) Triton-X in serum-free 
culture media. LDH activity was determined in the media and the cell lysate fraction by 
measuring the rate of disappearance of NADH from the reaction mixture (AOD3 4 0) using a 
Molecular Devices 96 well plate reader and SOFTmax PRO software. Percent 
extracellular LDH was calculated using the formula: % extracellular LDH = 100 x 
[(extracellular AOD/min) -r (extracellular + intracellular AOD/min)].
MTT Reduction:
A second cell viability assay was used measuring the reduction of a water soluble 
tétrazolium salt to formazan by the method of Slater (1963), modified by Mossman 
(1983). Briefly, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tétrazolium bromide (MTT)
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was dissolved in distilled, deionized H2 O at 5 mg/ml and further diluted to a working 
solution 1 ; 10 in Kreb’s Ringer Buffer (KRB). Extracellular media was aspirated from 12 
well plates. Two-hundred microliters of the MTT working solution, and 300 pi KRB was 
added to each well. Cells were incubated for 3 hr in a 37° C incubator to allow time for 
the reduction reaction. After 3 hr, 1.5 ml of 0.1 M HCl in isopropanol was added to the 
wells to solubilize the purple formazan crystals. Sealed well-plates were refrigerated 
overnight, and read on a Beckman DU450 spectrophotometer at 560 nm. Results were 
reported as a percent of the optical density produced by control wells from the same 
culture plate.
Glutamine Synthetase Assay:
Enzyme activity was determined by the colorimetric method of Meister (1985). 
Media was removed and astrocytes were rinsed with phosphate buffered saline. Cells 
were lysed with 1.1 ml of hypotonic buffer (10 mM imidizole-HCl, 0.5 mM EDTA, pH 
7.0). A 750 pi aliquot of the lysate was added to 750 pi of reaction mixture containing: 
0.25 M L-glutamine, 1.25 M hydroxy lamine, 4 mM manganese chloride, 200 mM arsenic 
acid, and 8 mM ADP. The samples were incubated for 60 minutes at 37° C. The reaction 
was rapidly halted in an ice bath with addition of 1.5 ml of acidic ferric chloride (0.37 M 
FeClg, 0.67 M HCl, and 0.2 M trichloroacetic acid). After allowing 30 min for color 
development, samples were centrifuged and read on a Beckmein DU650 
spectrophotometer at 555 nm. Values of y-glutamyl hydroxamate (yGH) produced per 
minute per milligram of protein were determined by comparison with a standard curve
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developed from a range of yGH concentrations. Values were reported as % control (yGH 
production in untreated cells). Additional experiments using purified sheep brain GS or 
astrocyte lysates were performed. These preparations were exposed to organotins for 60 
minutes to determine acute effects.
Glutamate Transport Assay:
Effects of organotins on glutamate transport by astrocytes was determined by 
measuring ^H-D-aspartate uptake (Wolpaw and Martin, 1984). Cell's were rinsed tliree 
times with HEPES Buffered Hank’s Balanced Salt (HBHS) solution (53 mM KCl, 4.4 
mM KH2PO4 , 136 mM NaCl, 6.5 mM Na2 HP0 4 , 55 mM D-glucose, 1.1 mM CaCl2 , 0.71 
mM MgS0 4 , 5.5 mM D-glucose, 10 mM HEPES). Cells were allowed to equilibrate to 
30° C for 10 min in HBHS. The buffer was replaced with pre-warmed 50 pM ^H-D- 
aspartate (0.056 mC/pmol) in HBHS for 5 min. The media was rapidly aspirated and 
rinsed three times with ice cold HBHS to remove extracellular ^H-D-aspartate. Cells 
were lysed overnight with 1 ml 0.4 M NaOH. 200 pi of sample was added to 1.5 ml 
liquid scintillation fluid and counted for 10 min on a Beckman LS 6500 liquid 
scintillation counter. The acute effects of organotins on glutamate transport were also 
determined by exposing astrocytes to TMT, TET, or TPT for 5 min while incubating with 
50 pM ^H-D-aspartate. Values were reported as the rate of D-aspartate transport/min/mg 
protein.
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Protein Determinations:
Protein determinations for the GS and glutamate transport assays were measured 
by the method of Bradford (1976).
Statistics:
The LDH, MTT, GS, and glutamate transport experiments were repeated with 
different culture preparations with n = 6  to 2 0  for each concentration and time point. 
Descriptive statistics, ANOVA, and Tukey’s multiple comparison test were determined 
with the GBSTAT® software program.
Results
Astrocytes were exposed to concentrations of 1-10 pM TMT, TET, and TPT for 
24 to 72 hr (Fig. 1). Figure 1A shows the effect of three concentrations of TMT on 
astrocyte viability. Clearly, the IpM and 5 pM concentrations were not toxic, while 10 
pM TMT produced a delayed cytotoxicity after 72 hr. Figure IB shows that the astrocyte 
cultures were more sensitive to TET exposure with concentrations as low as 2.5 pM 
producing significant cytotoxicity after 24 hr exposure. A concentration of 1 pM TET 
produced no discernible cytotoxicity. TPT produced almost 100% cell death in 
concentrations as low as 2.5 pM (Fig. 1C). After 72 hr, 1 pM TPT caused a small 
increase in extracellular LDH (19.4±6.2%).
Figure 2 shows that a 1 pM concentration of TMT and TET did not alter MTT 
reduction to formazan. Exposure to 1 pM TPT produced a significant increase in
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formazan production after 72 hr. This was the same time and concentration at which 
increased LDH release occurred.
The effect of subtoxic concentrations of organotins on the activity of GS was 
investigated. GS activity in unexposed cells ranged from 1-5 nmol/min/mg protein. The 
variation in control values is due to differences between culture preparations. Variation 
in sister cultures from the same preparation did not exceed 15%. These values are similar 
to those of 1-4 nmol/min/mg protein reported by others in rat astrocytes (Wu et a i, 1988; 
Collins et a i, 1994). Figure 3 presents data that shows there was no change in GS 
activity when cell homogenates were acutely exposed to the organotins and that there was 
no direct effect on purified sheep brain GS. Figure 4 shows that 1 pM TET and 1 pM 
TPT exposure decreased GS activity after 24 and up to 72 hr. GS activity was not 
decreased by IpM  TMT, while 5 pM TMT exposure decreased GS activity by 30% after 
48 hr.
Interaction of organotins with astrocytic glutamate transport was measured by 
quantifying the uptake of ̂ H-D-aspartate. Our control values of 2-2.5 nmol/min/mg 
protein were comparable to other reported transport rates of 1 - 2  nmol/min/mg protein in 
rat astrocytes (Bender et al., 1997; Miyazaki et al, 1997). In our study, none of the 
organotins affected transport activity with acute exposure at subtoxic concentrations (Fig. 
5). Figure 6  shows that 1 pM TET decreased D-aspartate transport activity in astrocytes 
at all three exposure times. A 30% decrease in D-aspartate transport 
activity was seen after 24 hr exposure to 1 pM TPT. The decreased transport activity 
after TPT exposure recovered to control levels after 48 hr. 1 pM TMT did not affect D-
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aspartate uptake. Additional experiments showed that increasing TMT concentrations to 
25 pM (data not shown), a concentration well above the cytotoxic threshold, did not 
affect glutamate transport.
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Figure 1 : Primary astrocytes were exposed to 1 - 1 0  juM organotins for 24-72 hours and 
LDH release was determined. For each data point, n = 6  to 26. (A) TMT exposure, (B) 
TET exposure, (C) TPT exposure. ** Significantly different from control, (p < 0.01).
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Figure 1 : Primary astrocytes were exposed to 1 - 10 pM organotins for 24-72 hours and 
LDH release was determined. For each data point, n = 6  to 26. (A) TMT exposure, (B) 
TET exposure, (C) TPT exposure. ** Significantly different from control, (p < 0.01).
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Figure 1 : Primary astrocytes were exposed to 1 - 1 0  |iM organotins for 24-72 hours and 
LDH release was determined. For each data point, n = 6  to 26. (A) TMT exposure, (B) 
TET exposure, (C) TPT exposure. ** Significantly different from control, (p < 0.01).
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Figure 2; Astrocytes were exposed to IpM TMT, TET, or TPT for 72 hours and 
formazan production was measured. Data is represented as percent of control levels of 
formazan produced. CTRL = control cells untreated with organotins. Bars represent n 
8  to 1 2 . * Significantly different from control, (p < 0.05).
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Figure 3 : Purified Sheep Brain GS was exposed to 1 0 0  pM TMT, IpM TET, or ipM  
TPT. Cell homogenates were exposed to the same concentrations of organotins. 0.1 unit 
of sheep brain GS produced 0.1 pmoie gGH/min. Data is presented as percent (%) of 
control values of y-glutamyl hydroxamate (gGH) produced. Sheep brain GS bars 
represent n -  3 and cell homogenate bars represent n = 7 to 8 . No significant difference 
fi*om control was detected.
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Figure 4: Cells were exposed to IpM  or 5 |iM  TMT, l|iM  TET, or l|iM  TPT for 24, 48 
or 72 hours. Data is presented as percent (%) of control values of y-glutamyl 
hydroxamate (gGH) produced. Bars represent n = 5 to 2 0 . * Significantly different from 
control, (* p < 0.05; ** p < 0.01).
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Figure 5: Untreated cells were exposed to l|iM  TMT, l|iM  TET, or IpM TPT for the 
incubation time of the assay (5 min). Data is presented as nmol D-aspartate uptake per 
minute per mg of protein. CTRL = control cells untreated with organotins. Bars 
represent n = 6 . No significant difference from control was detected.
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Figure 6 : Cells were exposed to IpM TMT, IpM TET, or l|iM  TPT for 24, 48 or 72 
hours. Rate of^H-D-aspartate uptake was determined. Data is presented as nmol D- 
aspartate uptake per minute per mg of protein. CTRL = control cells untreated with 
organotins. Bars represent n = 6  to 15. * Significantly different from control (* p < 0  05■
♦♦p<0.01) .  '
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Discussion
The effects of the three organotins on astrocyte viability were measured by LDH 
release. This data was used to determine the subtoxic concentrations needed to 
investigate the effects of organotins on glutamate homeostasis. The results from Figure 1 
show that 1 |aM TMT, 5 p.M TMT and 1 p.M TET did not produce increases in LDH 
release in our astrocyte culture system. TPT at 1 pM was close to the cytotoxic 
threshold, not producing cytotoxicity until after 72 hr exposure. Based on the data in 
Figure 1, we chose to investigate the effects of these concentrations of organotins on two 
specific astrocyte functions involved in glutamate homeostasis.
GS activity was decreased after chronic exposure to 5 pM TMT, 1 pM TET and 1 
pM TPT. TMT, TET, and TPT do not inhibit GS directly as shown by a lack of 
inhibition of both sheep brain GS and GS activity in acutely exposed cell lysates. It is 
possible that organotins produce reactive oxygen species (ROS) that inactivate GS. 
Purified sheep brain GS is inactivated by oxygen radicals produced by 6 -hydroxy- 
dopamine and enzyme activity is preserved by addition of superoxide dismutase (Schor, 
1988). Concentrations of TPT between 1 and 3 pM cause mitochondrial and intracellular 
calcium release within five minutes (Zazueta et al, 1994; Viviani et al, 1995). This 
calcium release could initiate any of a number of destructive biochemical cascades. One 
possibility is that oxygen radicals are generated after TPT induced calcium movement. 
Figure 2 shows that after chronic exposure to IpM TPT, mitochondrial activity is 
increased. Decreases in GS activity are seen before the increase in mitochondrial activity. 
The timing of these results suggests that GS inhibition is not a consequence of increased
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mitochondrial activity. Another possibility is that GS activity is affected by lower 
concentrations of ROS, generated prior to detectable changes in mitochondrial activity. 
The rapid calcium movement is not seen after TMT or TET exposure (Viviani et al,
1995), indicating that the consequences of increased intracellular calcium are unlikely to 
be a common mechanism for organotin inhibition of GS. The inhibition of GS by 5 pM 
TMT is delayed until 48 hr after exposure (Fig. 4), correlating with the delayed 
cytotoxicity seen at higher concentrations (Fig. 1 A). It is not clear why the TMT effect is 
delayed, but the extent of GS inhibition is essentially the same for all three organotins.
TET (1-100 pM) inhibits taurine transport in a glioma cell line without prolonged 
pre-incubation periods (Martin et a l, 1983). The same study found the IC5 0  for TET 
inhibition of glutamate transport after acute exposure to be > 100 pM. Our experiments 
with 1 pM concentrations showed that none of the organotins had an effect on the 
transporter after acute exposure. We saw an inhibition of glial glutamate transport by 
TET and TPT after 24 hr exposure. Loss of glutamate transport has not been implicated 
in gliotoxicity, but can increase the extracellular concentration of glutamate, triggering 
the neurodegeneration characteristic of excitotoxicity (Rothstein et al., 1996). Astrocytes 
exposed to 1 pM TET up to 72 hr maintain a decreased rate of glutamate uptake. TPT 
caused an initial decrease in glutamate transport, but in contrast to TET, the astrocytes 
seemed to recover transport activity after extended exposure (48 and 72 hr).
The combination of decreased GS and decreased transport after TET exposure 
could rapidly increase extracellular glutamate levels in the brain, triggering an excitotoxic 
event. These alterations in key astrocytic components of glutamate homeostasis could
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contribute to the cellular damage in CNS tissue caused by a prolonged glutamate 
challenge. It has been shown that a 50% inhibition of GS by methionine sulfoxlmine 
(MSO) increases glial glutamate uptake by 93% (Rothstein and Tabakoff, 1985). In our 
study, a 30-50% inhibition of GS after TET exposure accompanied a 50-60% decrease in 
transport. The lack of a similar transporter response after GS inhibition produced by 
TET suggests that this organotin is not affecting glutamate homeostasis the same way as 
the GS inhibitor MSO. TET actually decreased both GS and transport activity. This TET 
effect might be expected as a result of changes in the glutamate concentration gradient 
within a GS compromised astrocyte.
In contrast to TET, TMT produced a delayed decrease in GS activity without 
affecting glutamate uptake. TMT has been shown to decrease glutamate uptake in 
synaptosomal preparations at concentrations of 0.05-5 mM (Naalsund and Fonnum,
1986). However, these concentrations are highly toxic in most in vitro systems 
(Thompson et al, 1995) and 10 to 100 fold higher than the subtoxic concentrations used 
in our experiments. Even though a subtoxic concentration of TMT decreases GS activity 
(Fig. 4), in our laboratory only toxic concentrations of lOOpM and higher decrease both 
mechanisms of astrocyte glutamate homeostasis. It is unlikely that disruption of 
glutamate uptake can completely account for TMT neurotoxicity. TMT concentrations 
that are gliotoxic also decrease glutamate transport. A decrease in transport could 
increase extracellular concentrations of glutamate and possibly initiate excitotoxicity. 
However, a TC5 0  of 0.0IpM TMT has been reported in cortical neurons (Thompson et a l,
1996). The TMT concentration required to cause neuronal damage is much lower than
50
that reported to decrease glutamate transport. Therefore, TMT inhibition of glutamate 
transport probably does not contribute to its mechanism of neurotoxicity. The reported in 
vivo pathology after TMT exposure also indicates neuronal cell death without loss of 
astrocytes (Brock and O'Callaghan, 1987). TMT does decrease GS activity at 
concentrations that do not cause cytotoxicity without changes in glutamate transport.
This may allow for a slower accumulation of extracellular glutamate leading to the 
delayed toxicity observed in in vivo models.
TPT exposure also decreased GS activity up to 72 hr (Fig. 4) and glutamate 
transport only after 24 hr (Fig. 6 ). TPT at 1 pM did not produce cytotoxicity prior to 72 
hr. TPT does decrease glutamate transport activity after 24 hr exposure without evidence 
of cytotoxicity, but there are no sustained chronic effects. Effects of TPT on glutamate 
homeostasis preceded changes in LDH release and formazan production. These changes 
in cytotoxicity and mitochondrial activity did not appear to alter the effects of TPT on GS 
or glutamate transport, implying that the inhibition of GS and glutamate transport are not 
consequences of cell death.
In conclusion, three organotins with different specific in vivo toxicity all alter 
components of glutamate homeostasis. The unique neuropathology exhibited by TMT is 
not reflected in its actions on astrocytic components of glutamate homeostasis. In fact, 
TPT, a non-neurotoxic organotin, inhibits GS to a similar extent and also does not 
chronically inhibit glutamate transport. Only TET decreases both GS and glutamate 
transport activity. Inhibition of the two key astrocytic components of glutamate 
homeostasis may account for part of the neurotoxic action of TET. Regional distribution
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of GS and glutamate transport could account for differences between TMT and TET 
neurotoxic specificity.
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Conclusions:
1. The relative potency of the organotins in primary astrocyte culture was TPT > TBT, 
TET > TMT. TMT cytotoxicity was only apparent after 48 hours and at a concentration 
of 100 pM. The other three organotins TET, TBT and TPT produced cytotoxicity as 
early as 24 hours after 2.5 pM exposure.
2. TET, TBT and TPT produced different morphological changes than TMT. These 
observed morphological changes coincided with cytotoxicity measured by LDH release.
3. After 24 hour exposure, TMT and TET produced an increase in mitochondrial activity. 
This increase in metabolic activity preceded cell death. TBT and TPT decreased 
mitochondrial activity.
4. Chronic exposure to TMT, TPT, and TET decreased GS activity. Only TET decreased 
activity in both astrocytic components of glutamate homeostasis at a subtoxic 
concentration. This effect on glutamate homeostasis may contribute to the observed in 
vivo neurotoxicity of TET.
5. The order of effectiveness of cytotoxicity and interaction of organotins with 
components of glutamate homeostasis in astrocyte culture does not correlate with the 
reported in vivo pathology. Regional distribution of GS and glial glutamate transporters 
could contribute to differences in the regional specificity of neurotoxicity after TMT and 
TET exposure.
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